As an integrated drug discovery company Summit understand the needs of our clients and provides a highly industry focused service. We currently have multiple collaborations with over 25 companies from small Biotechs through to large pharmaceutical companies.

To date we have invested over $30m in our technology platform and have two state of the art facilities at Oxford and Cambridge. We have developed a suite of highly validated toxicology and safety pharmacology assays as well as a range of neuroscience and muscular-skeletal disease models and have extensive IP, know-how and expertise across these areas.

Our capability includes:

• A highly skilled team of over 35 zebrafish biologists and aquaculture technicians
• The capacity to house in excess of 50,000 adult zebrafish
• The capacity to generate 20,000 embryos a week for screening
• A custom built automation platform
• A proprietary method for quantifying compound uptake into zebrafish